Desde 1 classificações nos últimos 6 meses. Isto não é uma recomendação de investimento.
Comprar
0%
Manter
100%
Vender
0%
Sobre
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.